These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31217025)

  • 41. Pharmacovigilance: reporting requirements throughout a product's lifecycle.
    Lucas S; Ailani J; Smith TR; Abdrabboh A; Xue F; Navetta MS
    Ther Adv Drug Saf; 2022; 13():20420986221125006. PubMed ID: 36187302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience.
    Novakowski AK; Garcia-Gonzalez P; Wrigglesworth M; Stergachis A
    Global Health; 2018 Jul; 14(1):76. PubMed ID: 30053910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Big Data and Pharmacovigilance: Data Mining for Adverse Drug Events and Interactions.
    Ventola CL
    P T; 2018 Jun; 43(6):340-351. PubMed ID: 29896033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.
    Patadia VK; Coloma P; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Fornari C; Pedersen L; van der Lei J; Sturkenboom M; Trifirò G;
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):95-102. PubMed ID: 25487079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving the quality of workers' compensation health care delivery: the Washington State Occupational Health Services Project.
    Wickizer TM; Franklin G; Plaeger-Brockway R; Mootz RD
    Milbank Q; 2001; 79(1):5-33. PubMed ID: 11286095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Israel: health and beyond.
    Skorecki K; Horton R
    Lancet; 2017 Jun; 389(10088):2551-2562. PubMed ID: 28495106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy.
    Del Rio-Bermudez C; Medrano IH; Yebes L; Poveda JL
    J Pharm Policy Pract; 2020 Nov; 13(1):75. PubMed ID: 33292570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergies between veterinarians and para-professionals in the public and private sectors: organisational and institutional relationships that facilitate the process of privatising animal health services in developing countries.
    Woodford JD
    Rev Sci Tech; 2004 Apr; 23(1):115-35; discussion 391-401. PubMed ID: 15200091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using real-world evidence for pharmacovigilance and drug safety-related decision making by a resource-limited health authority: 10 years of experience in Taiwan.
    Chen WW; Lin CW; Huang WI; Chao PH; Gau CS; Hsiao FY
    Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1402-1413. PubMed ID: 32894792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data.
    Nyeland ME; Laursen MV; Callréus T
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):607-614. PubMed ID: 28397317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.
    Oliveira JL; Lopes P; Nunes T; Campos D; Boyer S; Ahlberg E; van Mulligen EM; Kors JA; Singh B; Furlong LI; Sanz F; Bauer-Mehren A; Carrascosa MC; Mestres J; Avillach P; Diallo G; Díaz Acedo C; van der Lei J
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):459-67. PubMed ID: 23208789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences.
    Ampadu HH; Hoekman J; Arhinful D; Amoama-Dapaah M; Leufkens HGM; Dodoo ANO
    Global Health; 2018 Nov; 14(1):109. PubMed ID: 30445979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Capacity for a global vaccine safety system: the perspective of national regulatory authorities.
    Graham JE; Borda-Rodriguez A; Huzair F; Zinck E
    Vaccine; 2012 Jul; 30(33):4953-9. PubMed ID: 22658930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outstanding scientist of the year 2006: Rogel Patawaran, BS.
    Rubin RA; Hazirjian CL
    J Long Term Eff Med Implants; 2006; 16(1):1-7. PubMed ID: 16566740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive IT-systems for big data analysis in medicine.
    Isakova J
    Int J Risk Saf Med; 2015; 27 Suppl 1():S108-9. PubMed ID: 26639685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why Are We Still Creating Individual Case Safety Reports?
    Streefland MB
    Clin Ther; 2018 Dec; 40(12):1973-1980. PubMed ID: 30420290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Questions about pharmaceutical expertise].
    Sauer F
    Sante Publique; 2012; 24(1):63-8. PubMed ID: 22730611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted Country.
    Nguyen KD; Nguyen PT; Nguyen HA; Roussin A; Montastruc JL; Bagheri H; Olsson S
    Drug Saf; 2018 Feb; 41(2):151-159. PubMed ID: 28975584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.